Search results
GSK Stock Dips on Delaware Court Ruling for Zantac Litigation
Zacks via Yahoo Finance· 21 hours agoGSK shares decline more than 7% in pre-market trading on Monday in response to an unfavorable ruling...
Delaware judge lets more than 70,000 Zantac lawsuits go forward
Reuters· 3 days agoA Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go...
GSK shares tumble 9% after 70,000 Zantac lawsuits allowed to move forward
Reuters via AOL· 1 day agoFollowing the ruling, analysts at J.P. Morgan said the potential liability that GSK could face from...
Trial in the fatal daytime ambush of rapper Young Dolph reset to September
Newsday· 21 hours agoA judge on Monday reset the trial date for a man charged with killing rapper Young Dolph in a...
Bill aimed at assisting public defenders falls short this spring, backers say they’ll try again in...
Chicago Tribune via Yahoo News· 15 hours agoA measure to create a statewide office to assist under-resourced public defenders stalled in the...
Delaware judge lets more than 70,000 Zantac lawsuits go forward
WHTC 1450 Holland· 3 days ago(Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug...
Jury selection set to begin in gun trial of Hunter Biden
NBC Universal via AOL· 23 hours agoHunter Biden’s lawyer, Abbe Lowell, has said that he wants to call the owner of the gun shop as a...
Health Care Roundup: Market Talk
The Wall Street Journal· 20 hours agoHowever, Sanofi’s exposure is smaller as they only sold the drug for a limited period of time compared to GSK. The rationale of Friday’s court ruling...
Andy Kim upended New Jersey politics. Now he’s on track to become a senator.
KPBS San Diego· 6 hours agoAndy Kim couldn’t rest one evening last September. The problem was his fellow New Jersey Democrat Sen. Bob Menendez. Last fall, Menendez was indicted for the second time on corruption charges ...
GSK shares tumble 9% after 70,000 Zantac lawsuits allowed to move forward By Investing.com
Investing.com· 1 day agoAnalysts indicated that GSK's potential liability from the litigation could exceed the $2 billion to...
